Ronald Rientsma
University of Amsterdam
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ronald Rientsma.
Journal of Clinical Investigation | 2000
Ronald P. van Rij; Hetty Blaak; Janny A Visser; Margreet Brouwer; Ronald Rientsma; Silvia Broersen; Ana-Maria de Roda Husman; Hanneke Schuitemaker
We demonstrated previously that CD45RA(+) CD4(+) T cells are infected primarily by syncytium-inducing (SI) HIV-1 variants, whereas CD45RO(+) CD4(+) T cells harbor both non-SI (NSI) and SI HIV-1 variants. Here, we studied evolution of tropism for CD45RA(+) and CD45RO(+) CD4(+) cells, coreceptor usage, and molecular phylogeny of coexisting NSI and SI HIV-1 clones that were isolated from four patients in the period spanning SI conversion. NSI variants were CCR5-restricted and could be isolated throughout infection from CD45RO(+) CD4(+) cells. SI variants seemed to evolve in CD45RO(+) CD4(+) cells, but, in time, SI HIV-1 infection of CD45RA(+) CD4(+) cells equaled infection of CD45RO(+) CD4(+) cells. In parallel with this shift, SI HIV-1 variants first used both coreceptors CCR5 and CXCR4, but eventually lost the ability to use CCR5. Phylogenetically, NSI and SI HIV-1 populations diverged over time. We observed a differential expression of HIV-1 coreceptors within CD45RA(+) and CD45RO(+) cells, which allowed us to isolate virus from purified CCR5(+) CXCR4(-) and CCR5(-) CXCR4(+) CD4(+) cells. The CCR5(+) subset was exclusively infected by CCR5-dependent HIV-1 clones, whereas SI clones were preferentially isolated from the CXCR4(+) subset. The differential expression of HIV-1 coreceptors provides distinct cellular niches for NSI and SI HIV-1, contributing to their coexistence and independent evolutionary pathways.
Virology | 2000
Hetty Blaak; Leonie J. Ran; Ronald Rientsma; Hanneke Schuitemaker
Antiviral Therapy | 2003
Sanjay U. C. Sankatsing; Rieneke M. E. van Praag; Ronald P. van Rij; Ronald Rientsma; Suzanne Jurriaans; Joep M. A. Lange; Jan M. Prins; Hanneke Schuitemaker
Antiviral Therapy | 2002
Ronald P. van Rij; Rieneke M. E. van Praag; Jan M. Prins; Ronald Rientsma; Suzanne Jurriaans; Joep M. A. Lange; Hanneke Schuitemaker
Investigative Ophthalmology & Visual Science | 2003
Sanjay U. C. Sankatsing; Praag van R. M. E; Rij van R. P; Ronald Rientsma; Suzanne Jurriaans; Joep M. A. Lange; Jan M. Prins; Hanneke Schuitemaker
American Journal of Sports Medicine | 2002
Rij van R. P; Praag van R. M. E; Jan M. Prins; Ronald Rientsma; Suzanne Jurriaans; Joep M. A. Lange; Hanneke Schuitemaker
American Journal of Sports Medicine | 2002
Rij van R. P; Janny A Visser; Praag van R. M. E; Ronald Rientsma; Jan M. Prins; Joep M. A. Lange; Hanneke Schuitemaker
Current Opinion in Gastroenterology | 2000
Hetty Blaak; Leonie Ran; Ronald Rientsma; Hanneke Schuitemaker
Current Opinion in Gastroenterology | 2000
Rij van R. P; Hetty Blaak; Janny A Visser; Margreet Brouwer; Ronald Rientsma; Silvia Broersen; Roda Husman de A. M; Hanneke Schuitemaker